Fagiuoli, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 545
EU - Europa 311
AS - Asia 146
SA - Sud America 8
AF - Africa 3
Totale 1.013
Nazione #
US - Stati Uniti d'America 540
SE - Svezia 97
CN - Cina 60
DE - Germania 59
IT - Italia 55
SG - Singapore 46
IE - Irlanda 25
UA - Ucraina 19
FR - Francia 16
ID - Indonesia 14
FI - Finlandia 11
GB - Regno Unito 11
BR - Brasile 8
TR - Turchia 8
RU - Federazione Russa 7
IN - India 6
BZ - Belize 4
JP - Giappone 4
NL - Olanda 4
CZ - Repubblica Ceca 2
HK - Hong Kong 2
KR - Corea 2
PH - Filippine 2
BE - Belgio 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
MX - Messico 1
NG - Nigeria 1
RO - Romania 1
RS - Serbia 1
TN - Tunisia 1
Totale 1.013
Città #
Chandler 88
Houston 55
Ashburn 54
Redmond 45
Singapore 42
Chicago 27
Dublin 25
Rome 18
Nanjing 15
San Mateo 15
Jakarta 14
Jacksonville 13
Wilmington 13
New York 11
San Jose 10
Boston 9
Cattolica 9
Dearborn 8
Milan 8
Helsinki 7
Paris 7
Princeton 7
Las Vegas 6
Ann Arbor 5
Izmir 5
Zhengzhou 5
Belize City 4
Lawrence 4
Marseille 4
Moscow 4
Seattle 4
Simi Valley 4
Woodbridge 4
Albuquerque 3
Beijing 3
Bologna 3
Capelle 3
Changsha 3
Fairfield 3
London 3
Los Angeles 3
Nanchang 3
Norwalk 3
Shenyang 3
Tokyo 3
Boardman 2
Cambridge 2
Fremont 2
Hebei 2
Jiaxing 2
Kunming 2
Mountain View 2
Munich 2
Redwood City 2
Seoul 2
São Paulo 2
Tianjin 2
Abidjan 1
Amsterdam 1
Andover 1
Augusta 1
Bangalore 1
Bari 1
Brdo 1
Bremen 1
Brno 1
Brussels 1
Buffalo 1
Changchun 1
Gavirate 1
Guangzhou 1
Hangzhou 1
Hefei 1
Hong Kong 1
Jerusalem 1
Jinan 1
Katerini 1
Kocaeli 1
Lagos 1
Lanzhou 1
Mandaluyong City 1
Mexico City 1
Mumbai 1
Nuremberg 1
Orange 1
Perugia 1
Piacenza 1
Pittsburgh 1
Saint Louis 1
San Giorgio di Piano 1
Shanghai 1
Slough 1
Stockholm 1
University Park 1
Vigevano 1
Walnut 1
Washington 1
Wuhan 1
Zanjan 1
Zurich 1
Totale 652
Nome #
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 211
Gut microbiota in autism and mood disorders 137
Gut microbiota in autism and mood disorders 115
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 92
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 73
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 72
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 68
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 64
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program 54
Real life experiences in HCV management in 2018 41
Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use 40
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 37
Balancing Donor and Recipient Risk Factors in Liver Transplantation: The Value of D-MELD With Particular Reference to HCV Recipients 19
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study 15
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 11
Totale 1.049
Categoria #
all - tutte 4.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.481


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202065 0 0 0 0 5 8 11 2 7 3 9 20
2020/2021101 14 6 8 7 6 5 2 5 21 9 14 4
2021/2022105 10 3 3 5 9 5 1 16 5 6 24 18
2022/2023274 29 39 19 28 20 32 9 33 41 10 6 8
2023/2024142 8 34 5 5 10 12 4 37 2 5 8 12
2024/202583 5 3 26 19 30 0 0 0 0 0 0 0
Totale 1.049